Tissue engineering by self-assembly

A long-standing limitation in tissue engineering has been the dogmatic reliance on synthetic scaffolds for building tissues with significant mechanical functions despite their deleterious effects (inflammation, scarring, infection, etc.). Tissue engineering by self-assembly (TESA) is a novel approach that relies on the cell's ability to produce natural extracellular matrix TESA can be used to produce structures that have physiological strength and are not recognized as foreign in vivo. We have developed a tissue-engineered blood vessel that has shown great promise as an arteriovenous shunt. Here, we review our journey from bench-top to bedside and discuss future applications of the TESA approach.

[1]  Takako Sasaki,et al.  Fibulin-2 and Fibulin-5 Cooperatively Function to Form the Internal Elastic Lamina and Protect From Vascular Injury , 2010, Arteriosclerosis, thrombosis, and vascular biology.

[2]  R T Tranquillo,et al.  Magnetically orientated tissue-equivalent tubes: application to a circumferentially orientated media-equivalent. , 1996, Biomaterials.

[3]  Dawn Pedrotty,et al.  Blood vessels engineered from human cells , 2005, The Lancet.

[4]  M. Harmsen,et al.  Endothelial progenitor cell dysfunction in patients with progressive chronic kidney disease. , 2009, American journal of physiology. Renal physiology.

[5]  H Green,et al.  Growth of cultured human epidermal cells into multiple epithelia suitable for grafting. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[6]  P. Jones,et al.  The effect of ascorbic acid on the nature and production of collagen and elastin by rat smooth-muscle cells. , 1980, The Biochemical journal.

[7]  Laura E Niklason,et al.  Human arteries engineered in vitro , 2003, EMBO reports.

[8]  E Bell,et al.  Living tissue formed in vitro and accepted as skin-equivalent tissue of full thickness. , 1981, Science.

[9]  A. Ylppo.  Children's Clinic, Helsinki. , 1948, Lancet.

[10]  T. Matsuda,et al.  Self-organized, tubular hybrid vascular tissue composed of vascular cells and collagen for low-pressure-loaded venous system. , 1995, Cell transplantation.

[11]  T. Matsuda,et al.  Venous reconstruction using hybrid vascular tissue composed of vascular cells and collagen: tissue regeneration process. , 1996, Cell transplantation.

[12]  N. L'Heureux,et al.  Mechanical properties of completely autologous human tissue engineered blood vessels compared to human saphenous vein and mammary artery. , 2009, Biomaterials.

[13]  J. Andrades,et al.  Demineralized bone matrix mediates differentiation of bone marrow stromal cells in vitro: Effect of age of cell donor , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[14]  N. L'Heureux,et al.  Human tissue-engineered blood vessels for adult arterial revascularization , 2007, Nature Medicine.

[15]  S. Fazel,et al.  Increasing donor age adversely impacts beneficial effects of bone marrow but not smooth muscle myocardial cell therapy. , 2005, American journal of physiology. Heart and circulatory physiology.

[16]  Stefanie Dimmeler,et al.  Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease , 2004, Circulation.

[17]  M. Verhaar,et al.  Endothelial progenitor cell dysfunction in rheumatic disease , 2009, Nature Reviews Rheumatology.

[18]  E Bell,et al.  A blood vessel model constructed from collagen and cultured vascular cells. , 1986, Science.

[19]  Alexis Carrel,et al.  The culture of organs , 1938 .

[20]  G. Beck,et al.  Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. , 2008, JAMA.

[21]  T. McAllister,et al.  Haemodialysis access via tissue-engineered vascular graft – Authors' reply , 2009, The Lancet.

[22]  R. Guidoin,et al.  A Pathological Study of Arterial Prostheses Surgically Excised after Overt Clinical Infection , 1991, Journal of biomaterials applications.

[23]  L. Germain,et al.  A human tissue‐engineered vascular media: a new model for pharmacological studies of contractile responses , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  James M. Anderson,et al.  Foreign body reaction to biomaterials. , 2008, Seminars in immunology.

[25]  H. C. van der Mei,et al.  The phenomenon of infection with abdominal wall reconstruction. , 2007, Biomaterials.

[26]  J. Babensee.  Interaction of dendritic cells with biomaterials. , 2008, Seminars in immunology.

[27]  Thomas A. Mustoe, MD, FACS,et al.  Effect of age and hypoxia on TGFβ1 receptor expression and signal transduction in human dermal fibroblasts: Impact on cell migration , 2002, Journal of cellular physiology.

[28]  M. Lussier,et al.  Keratin 19 as a biochemical marker of skin stem cells in vivo and in vitro: keratin 19 expressing cells are differentially localized in function of anatomic sites, and their number varies with donor age and culture stage. , 1996, Journal of cell science.

[29]  G. Kopchok,et al.  The role of internal elastic laminae damage in the development of canine arteriosclerosis. , 1990, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[30]  Marcin Maruszewski,et al.  Effectiveness of haemodialysis access with an autologous tissue-engineered vascular graft: a multicentre cohort study , 2009, The Lancet.

[31]  R Langer,et al.  Functional arteries grown in vitro. , 1999, Science.

[32]  F A Auger,et al.  A completely biological tissue‐engineered human blood vessel , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  C. Stehman-Breen,et al.  Vascular access survival and incidence of revisions: a comparison of prosthetic grafts, simple autogenous fistulas, and venous transposition fistulas from the United States Renal Data System Dialysis Morbidity and Mortality Study. , 2001, Journal of vascular surgery.

[34]  J. Coburn,et al.  IgG antibodies against bovine serum albumin in humans--their prevalence and response to exposure to bovine serum albumin. , 2005, Journal of immunological methods.

[35]  S. Wilson,et al.  Superiority of Autogenous Arteriovenous Hemodialysis Access: Maintenance of Function with Fewer Secondary Interventions , 2004, Annals of vascular surgery.

[36]  F A Auger,et al.  In vitro construction of a human blood vessel from cultured vascular cells: a morphologic study. , 1993, Journal of vascular surgery.

[37]  R. Walker,et al.  Development of antibodies to fetal calf serum with arthus-like reactions in human immunodeficiency virus-infected patients given syngeneic lymphocyte infusions. , 1997, Blood.

[38]  R. D'Incà,et al.  Reduced Endothelial Progenitor Cell Number and Function in Inflammatory Bowel Disease: A Possible Link to the Pathogenesis , 2009, The American Journal of Gastroenterology.

[39]  E. Lakatta,et al.  Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. , 1994, Circulation research.

[40]  F. Grinnell,et al.  Collagen processing, crosslinking, and fibril bundle assembly in matrix produced by fibroblasts in long-term cultures supplemented with ascorbic acid. , 1989, Experimental cell research.

[41]  H. Green,et al.  Growth of cultured mammalian cells on secondary glucose sources. , 1974, Cell.

[42]  R. Tranquillo,et al.  Mechanisms of stiffening and strengthening in media-equivalents fabricated using glycation. , 2000, Journal of biomechanical engineering.

[43]  L. Muul,et al.  Immune response to fetal calf serum by two adenosine deaminase-deficient patients after T cell gene therapy. , 2002, Human gene therapy.

[44]  M. Joffe,et al.  Determinants of successful synthetic hemodialysis vascular access graft placement. , 2003, Journal of vascular surgery.

[45]  S. Combs,et al.  Effects of ascorbic acid on proliferation and collagen synthesis in relation to the donor age of human dermal fibroblasts. , 1994, The Journal of investigative dermatology.

[46]  L. Germain,et al.  Use of human vessels and human vascular smooth muscle cells in pharmacology , 1996, Cell Biology and Toxicology.

[47]  J. Mulliken,et al.  GRAFTING OF BURNS WITH CULTURED EPITHELIUM PREPARED FROM AUTOLOGOUS EPIDERMAL CELLS , 1981, The Lancet.